Home Antibody All anti-FANCC antibodies
Also for FANCC (NM_000136)
|Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 275 of FANCC|
|WB, IHC, IF
||WB:1:500-1:3000; IHC:1:100; IF:1:100-1:500;
|0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.|
|Purified by antigen-affinity chromatography.
|Homo sapiens Fanconi anemia, complementation group C (FANCC), transcript variant 1|
|FA3; FAC; FACC|
|The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group C. [provided by RefSeq]|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Sample (30 ug of whole cell lysate) A: H1299 ( anti-FANCC antibody diluted at 1:1000)
Immunohistochemical analysis of paraffin-embedded OVCA xenograft, using FANCC(anti-FANCC antibody) antibody at 1:100 dilution.
Immunofluorescence analysis of paraformaldehyde-fixed HeLa, using FANCC(anti-FANCC antibody) antibody at 1:200 dilution.